Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Bullboard Posts
Post by Maximumon Dec 10, 2018 8:30am
120 Views
Post# 29090512

Invest in a biotech/pharma company

Invest in a biotech/pharma company
means: you check product pipeline. and you must know that the really interesting time comes with phase 3, possible to licence (RVV is now in 2a/2b). to develop a drug it normally takes 10 years from beginning to sale. It's like a domino game, but it takes 6 years to build up the stones, and then the stones fall very slow, if they fall ever. We can be happy that RVV has several pillars: 1. Distribution Rights for Axim products canada. Drugs in phase 2a/2b, patetend, Ready to License 2019. Two orphan drug designations. Cannabis plant with possibility to create/sell cannabis/oil products also. But when i write it's like selling a fridge to an inuit. because all is written more or less in Company presentation, and when you count 1+1 you see that 2019 is the year of RVV.
Bullboard Posts